March 5, 2007 - Viatronix Inc. recently announced the installment of its clinically proven V3D Colon module that provides automatic post processing and diagnostic tools which reportedly improves speed and thoroughness of radiologist interpretation, at two Massachusetts hospitals.
If you enjoy this content, please share it with a colleague
Related Content
February 6, 2024 — An update to the CT Colonography Reporting and Data System (C-RADS) has been published Jan. 30 in the ...
A team of Johns Hopkins data researchers is studying the economic and safety implications associated with the devices used to perform colonoscopies as a disposable version inches closer to widespread availability.
A new study finds that trends in colonoscopy rates did not fully align with the increase in colorectal cancer (CRC) in younger adults, adding to evidence that the rise in early onset CRC is not solely a result of more detection. The study is published early online in the Journal of Medical Screening.
Check-Cap Ltd. has initiated its U.S. pilot study of the C-Scan system for prevention of colorectal cancer through detection of precancerous polyps, following Institutional Review Board (IRB) approval and full Investigational Device Exemption (IDE) application approval by the U.S. Food and Drug Administration (FDA). The first patients have ingested C-Scan, a preparation-free capsule, at the New York University School of Medicine.
https://www.congress.gov/bill/115th-congress/house-bill/1298?q=%7B%22se… cancer care advocacy groups and medical societies are calling on Congress to pass the CT Colonography Screening for Colorectal Cancer Act (S.3465/HR 1298). The bipartisan bill introduced in the U.S. Senate September 19 would provide Medicare coverage for screening computed tomography colonography (CTC), commonly known as virtual colonoscopy.
Check-Cap Ltd. announced the interim results for its post-CE approval study of the C-Scan system Version 3, an ingestible, capsule-based device for preparation-free colorectal cancer (CRC) screening. The company said data from the multicenter clinical investigation showed promising results for detecting patients with polyps in an un-prepped colon.
An updated American Cancer Society guideline says colorectal cancer screening should begin at age 45 for people at average risk. The recommendation is based in part on data showing rates of colorectal cancer are increasing in young and middle-aged populations.
February 8, 2018 – The U.S. Food and Drug Administration (FDA) announced on February 7, 2018, that Pentax Medical’s ...
August 31, 2017 — A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper ...
People with insurance policies that cover computed tomography (CT) colonography for colorectal cancer screening are almost 50 percent more likely to get screened than those whose policies don’t cover the procedure, according to a new study appearing online in the journal Radiology.